Brief history of enhanced RSV disease.In 1966, a formalin-inactivated vaccine against RSV (FIRSV) was administered to infants and children in four studies in the United States (
26–29). The immunized children were exposed to RSV in the community, and those children who were seronegative for the virus before vaccination experienced a significant increase in the frequency and severity of RSV LRTI. This enhanced form of RSV disease presented with fever, wheezing, and bronchopneumonia and led to frequent hospitalizations (80% in FIRSV recipients versus 5% in controls among RSV-infected children in one study) (
26). In fact, two immunized infants died as toddlers as a consequence of subsequent RSV infection (
26).